Form 4: BioAtla Director Sylvia McBrinn Granted Restricted Stock Units

BioAtla, Inc. Director Sylvia McBrinn was granted 23,500 shares of common stock through a time-based restricted stock unit award, increasing her beneficial ownership to 59,125 shares.

Summary

• Sylvia McBrinn, a Director of BioAtla, Inc. (BCAB), was granted 23,500 shares of common stock.
• The shares were granted as a time-based Restricted Stock Unit (RSU) award.
• The transaction date for this grant was June 18, 2025.
• The RSU award will vest 100% on the earlier of June 18, 2026, or the next Company annual meeting of stockholders.
• Vesting is contingent upon Ms. McBrinn's continued service to the company through the vesting date.
• Following this transaction, Ms. McBrinn's total beneficial ownership of BioAtla common stock is 59,125 shares.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it indicates standard compensation practices and aligns director interests with shareholders, without revealing any negative operational or financial news.

Positives

• The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, as the value of the award is tied to the company's stock performance.
• It represents a standard form of non-cash compensation for board members, indicating ongoing commitment and retention of key personnel.

Risks

• The vesting of the RSU award is subject to Sylvia McBrinn's continued service, meaning the shares could be forfeited if her service terminates before the vesting date.

Future Outlook

The Restricted Stock Unit award is set to vest 100% on the earlier of June 18, 2026, or the next Company annual meeting of stockholders, provided the reporting person continues her service.

Industry Context

This transaction is a routine equity compensation grant to a director, common across publicly traded companies in the biotechnology and pharmaceutical sectors to attract and retain talent and align interests with shareholders.

Corporate Governance

Related Party Transactions

• The grant of 23,500 Restricted Stock Units to Sylvia McBrinn, a Director of BioAtla, Inc., constitutes a related party transaction as it involves compensation from the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with the company's stock performance, potentially leading to more shareholder-focused decision-making.
• Employees: While not directly impacting employees, such compensation practices can set a precedent for executive and board remuneration within the company.

Next Steps

• The RSU award will vest on the earlier of June 18, 2026, or the next Company annual meeting of stockholders, subject to continued service.

Key Dates

Keywords

BioAtla, BCAB, Restricted Stock Units, RSU, Insider Transaction, SEC Form 4, Director Compensation, Equity Grant, Beneficial Ownership